Summer is almost over! If you haven’t planned Fall advertising, you’re not too late! Reach out today to Undine McEvoy, firstname.lastname@example.org!
Connect with your stakeholders in our Virtual Conference Center, HE-Xpo. It’s a greate marketing and educational tool (use for training too!) Contact email@example.com!
|IN THIS ISSUE|
Did you know there are about 20,000 HEOR/PRMA Professionals and Allied Suppliers? HealthEconomics.Com speaks to just about every one of them, each week, from Bangladesh to Bangor, Maine! We can help YOU speak to them too. Options for every budget! Contact us today.
|SPOTLIGHT 1 OF THE WEEK||SPOTLIGHT 2 OF THE WEEK|
|20% of Clinically Effective Drugs are Not Reimbursed. Why?|
Reimbursement Risk Tracker (RRT) focuses specifically on the behavior of Health Technology Assessment (HTA) agencies around the world, offering an insightful look into the complex and often confusing drug development process. To learn more about RRT, see here. (Source: ContextMatters, 8/20/14).
This article covers four ways you can improve your market access effort by optimizing your collaborative effort. Read more here. (Source: Andre Moa, Tribeca Knowledge, 8/20/14)
Jefferson School of Population Health is accepting registration for their FALL Population Health Academy. The Population Health Academy is a 40-hour continuing education credit program running October 13-17, 2014. More information on the course pricing and registration available here. (Source: Jefferson School of Population Health, 8/19/14).
Let us help drive traffic to your symposia, booth and presentations with our ISPOR Beijing Social Media Bullhorn Package. HealthEconomics.Com has been cited as Top Influential leader in the health outcomes and health economics research community for the last 7 ISPOR Meetings! We do Social Share like none other!
After gaining access to 10,000 patient records in China, Roche applied its Real World Data strategy to the records and this led them to reduce the patients process from 40 steps to just 9.
But first, follow @www_healthecon! Then follow these 10, for a vault of knowledge on all things healthcare.
DARE (Database of Abstracts of Reviews of Effects) is focused primarily on systematic reviews that evaluate the effects of health care interventions and the delivery and organisation of health services. See what’s new here
This report is an essential tool for pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, benefit managers, managed care executives, healthcare policy analysts, consultants, and investors. Purchase available here. (Source: Drug Channels Institute).
ISPOR is now entering its 20th year of being a member-driven Society and the timing has never been better to become a member. Join because….more here.
|Link of the Week||Conference of the Week||Webinar of the Week|
Clinical Trials in Oncology: A Patient’s Perspective
September 25th, 2014. 11:00 am ET.